Kelsey Collins Wins NEXT Award for Research Linking Fat Tissue to Osteoarthritis — American Academy of Orthopaedic Surgeons

Event summary

Kelsey H. Collins, PhD, received the 2026 NEXT Award for research demonstrating fat tissue's role in osteoarthritis (OA) development and pain.
Collins' work challenges the traditional 'wear and tear' view of OA, showing it may be a systemic condition influenced by metabolic and immune factors.
Studies using rat and mouse models showed that diet-induced obesity can drive OA independently of mechanical overloading.
The research identified adipose-derived factors like leptin as potential therapeutic targets for OA treatment.
Collins plans to further investigate the interface between fat signaling, obesity, and aging to develop new biologic drugs.

The big picture

Kelsey Collins' award-winning research represents a significant shift in understanding osteoarthritis, moving away from the traditional 'wear and tear' model towards a systemic condition influenced by metabolic factors. This work could open new avenues for biologic drug development, potentially addressing the growing economic burden of OA which has doubled to over $136 billion annually. The findings challenge current medical practices that focus on localized knee treatments, suggesting a need for more holistic approaches to managing OA.

What we're watching

Therapeutic Development: Whether Collins' findings will accelerate the development of biologic drugs targeting adipose-derived factors in OA treatment.
Research Validation: The pace at which subsequent studies validate or challenge the systemic origins of OA hypothesis.
Clinical Translation: How quickly these research insights transition from mouse and rat models to human clinical trials.